Poland: an interesting Self-Medication and Pharma market next to Germany
Poland’s Self-Medication and Pharma market underwent changes in the past few years, putting them on the map of European markets full of opportunities.
Pharmaceutical exports, especially to Western Europe, have been strong and on the rise, as local producers have increased their focus on more advanced-medicine markets in the last few years. Poland’s consumer healthcare and pharma market value reached USD 8,9 billion in 2021, ex-factory, and is expected to reach USD 18,42 billion by 2035, according to Chameleon Pharma Consulting Group forecasts.
Reforms over the last 10 years have led to a more mature and transparent environment in healthcare. Major changes were introduced in the pricing and reimbursement system, with the goal of increasing transparency, reducing drug spending, and providing higher access to innovations.
Chameleon Pharma Consulting Group has developed a systematic partner search process that can identify the most suitable local partner for you in Poland in only 10-12 weeks. Simply contact us for more details!
Poland OTC and pharma market in 2035
USD 18,42 Billion
OTC and pharma market size, ex-factory
OTC and pharma market growth
Poland in numbers
Interested in this market?
We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.